KIR3DL1 and triple-negative breast carcinoma: Although we observed no associations among the overall IO-naïve cohort for KIR-ligand present/missing status, we did observe that KIR-ligand present/missing status influenced clinical outcome in the triple-negative breast cancer (TNBC) patients (n = 33 or 31).